| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Derakhshan Behrad is a Chief Business Officer at Edgewise Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $923K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | Chief Business Officer | Sale+OE | 2,491 | $13.39 | $33,360.47 | -9.5% | +36.5% | - | |
| May 2, 2025 | EWTX Edgewise Therapeutics, Inc. | Chief Business Officer | Sale+OE | 1,691 | $16.45 | $27,824.05 | -7.7% | -15.7% | +81.0% | |
| Feb 5, 2025 | EWTX Edgewise Therapeutics, Inc. | Chief Business Officer | Sale+OE | 10,000 | $30.03 | $300,300.00 | -37.3% | -52.1% | -9.5% | |
| Sep 20, 2024 | EWTX Edgewise Therapeutics, Inc. | Chief Business Officer | Sale+OE | 42,068 | $29.03 | $1,221,133.08 | -73.6% | +8.9% | -49.6% | |
| May 2, 2024 | EWTX Edgewise Therapeutics, Inc. | Chief Business Officer | Sale+OE | 1,718 | $18.91 | $32,487.38 | -11.3% | -11.7% | -12.3% | |
| Feb 9, 2024 | EWTX Edgewise Therapeutics, Inc. | Chief Business Officer | Sale+OE | 10,000 | $20.03 | $200,258.04 | -32.2% | +2.7% | +35.4% | |
| May 2, 2023 | EWTX Edgewise Therapeutics, Inc. | Chief Business Officer | Sale+OE | 1,747 | $8.90 | $15,556.86 | -19.9% | -16.7% | +117.3% |